November 20, 2013 – The U.S. Food & Drug Administration (FDA) issued a warning today about the risk of heart attack and death that has recently been associated with the nuclear stress agent Lexiscan (generic: regadenoson). The FDA has approved changes to Lexiscan warning labels to reflect these potential complications, and updated recommendations for use of the drug. Lexiscan is used during cardiac nuclear stress tests on patients who cannot exercise adequately to help identify coronary artery disease (CAD).
Free Lexiscan Lawsuit Evaluation: If you or a loved one has been injured by Lexiscan, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of Lexiscan and we can help.
What is Lexiscan?
Manufactured and marketed by Astellas Pharma US, Lexiscan (regadenoson) is designed to identify CAD by dilating the arteries of the heart and increasing blood flow to help find obstructions in the arteries. Lexiscan causes blood to flow to the unblocked arteries, which can reduce blood flow in the obstructed artery. In some cases, this reduced blood flow can lead to a potentially fatal heart attack.
Drug Safety Communication – Lexiscan Linked to Heart Attacks, Death
According to the FDA, the Warnings & Precautions section of Lexiscan labels previously contained verbiage about the risk of heart attacks and death with use of the medication. However, recent submissions to the FDA Adverse Event Reporting System (FAERS) database have prompted approval changes to the drug label to include updated recommendations for use.
The FDA is recommending that physicians screen all nuclear stress test candidates to determine their ability to take Lexiscan. The medication should be avoided in patients with symptoms of unstable angina or cardiovascular instability, as these individuals are at an increased risk for developing severe cardiovascular reactions. Cardiac resuscitation equipment and trained staff should be available before treating any patient with Lexiscan.
Lexiscan Side Effects
In addition to having the potential to cause heart attacks and death, Lexiscan has also been associated with the following moderate side effects:
- arm, back, or jaw pain
- chest pain or discomfort
- difficult or labored breathing
- fast or irregular heartbeat
- shortness of breath
- tightness in the chest
Symptoms of a Lexiscan overdose may include:
- feeling of warmth
- increased heart rate
- redness of the face, neck, arms, and occasionally, upper chest
Do I Have a Lexiscan Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Lexiscan lawsuits. We are handling individual litigation nationwide and currently accepting new Lexiscan injury and death cases in all 50 states.
Free Lexiscan Lawsuit Evaluation: If you or a loved one has been injured by Lexiscan, you should contact our law firm immediately. You may be entitled to compensation by filing a Lexiscan suit and we can help.